Beck Capital Management’s AbbVie ABBV Stock Holding History

Beck Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,567	Closed	-$3.12M	–	104
2023 Q1	$3.12M	Buy	19,567 +17	+0.1%	+$2.6K	1.33%	19
2022 Q4	$3.16M	Sell	19,550 -293	-1%	-$44.9K	1.33%	17
2022 Q3	$2.66M	Sell	19,843 -8,791	-31%	-$1.26M	1.14%	28
2022 Q2	$4.38M	Sell	28,634 -1,464	-5%	-$224K	1.97%	9
2022 Q1	$4.88M	Buy	30,098 +15,206	+102%	+$2.21M	1.49%	13
2021 Q4	$2.02M	Buy	14,892 +914	+7%	+$108K	0.62%	67
2021 Q3	$1.51M	Buy	13,978 +1,303	+10%	+$149K	0.51%	74
2021 Q2	$1.43M	Sell	12,675 -193	-1%	-$21.7K	0.48%	74
2021 Q1	$1.39M	Buy	12,868 +465	+4%	+$49.7K	0.53%	64
2020 Q4	$1.33M	Buy	+12,403	New	+$1.19M	0.55%	58
2018 Q3	–	Sell	-40,651	Closed	-$3.77M	–	102
2018 Q2	$3.77M	Sell	40,651 -1,028	-2%	-$100K	1.82%	23
2018 Q1	$3.94M	Buy	41,679 +3,828	+10%	+$421K	1.82%	18
2017 Q4	$3.66M	Buy	37,851 +2,525	+7%	+$238K	1.61%	24
2017 Q3	$3.14M	Buy	35,326 +25,824	+272%	+$1.97M	1.5%	27
2017 Q2	$691K	Buy	+9,502	New	+$639K	0.35%	63
2016 Q4	–	Sell	-3,200	Closed	-$202K	–	89
2016 Q3	$202K	Buy	+3,200	New	+$207K	0.12%	98
2015 Q3	–	Sell	-32,828	Closed	-$2.21M	–	98
2015 Q2	$2.21M	Buy	32,828 +25,560	+352%	+$1.67M	1.18%	29
2015 Q1	$425K	Hold	7,268	–	–	0.24%	92
2014 Q4	$476K	Sell	7,268 -768	-10%	-$48.4K	0.28%	86
2014 Q3	$456K	Buy	8,036 +9	+0.1%	+$500	0.32%	91
2014 Q2	$453K	Buy	8,027 +325	+4%	+$17.1K	0.3%	97
2014 Q1	$401K	Hold	7,702	–	–	0.31%	99
2013 Q4	$367K	Buy	+7,702	New	+$379K	0.3%	94

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Beck Capital Management's ABBV Position: Q2 2023 in Review

Beck Capital Management sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 19,567 shares — an estimated $3.12M sold.

Beck Capital Management first reported a position in ABBV in Q4 2013 and held it in 23 quarters. The position peaked at $4.88M in Q1 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

Beck Capital Management reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
Beck Capital Management sold 19,567 AbbVie shares in Q2 2023, an estimated $3.12M.
Beck Capital Management first reported a position in AbbVie in Q4 2013 and held it in 23 quarters.
Beck Capital Management's AbbVie position peaked at $4.88M in Q1 2022.
3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Beck Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.